Pretransfection with miR-374a-5p reduced monocyte-driven CD4+ T cell chemoattractant capacity when either LPS-stimulated HC monocytes or unstimulated monocytes from patients with active IBD were used (Fig. 9 B). Here, CD4 is linked to inflammatory bowel disease.